Overview

Nalbuphine Versus Morphine for Mucositis Pain in Pediatric Cancer Patients

Status:
Completed
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
Evaluation of safety and efficacy of Nalbuphine versus Morphine patient controlled analgesia (PCA) for mucositis pain in pediatric cancer patients
Phase:
Phase 3
Details
Lead Sponsor:
Children's Cancer Hospital Egypt 57357
Treatments:
Morphine
Nalbuphine